These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1472630)

  • 21. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Takao Y; Yamaguchi Y; Akazawa S; Nagataki S
    Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
    J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
    Akawaza S; Kawasaki E; Yano M; Abiru N; Yamaguchi Y; Nagataki S
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender.
    Zimmet PZ; Elliott RB; Mackay IR; Tuomi T; Rowley MJ; Pilcher CC; Knowles WJ
    Diabet Med; 1994 Nov; 11(9):866-71. PubMed ID: 7705024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase.
    Takino H; Kawasaki E; Yano M; Matsumoto K; Uotani S; Okuno S; Takao Y; Yamasaki H; Yamaguchi Y; Akazawa S
    J Autoimmun; 1994 Jun; 7(3):389-98. PubMed ID: 7916910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
    Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T
    Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
    Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
    Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase.
    Christie MR; Hollands JA; Brown TJ; Michelsen BK; Delovitch TL
    J Clin Invest; 1993 Jul; 92(1):240-8. PubMed ID: 8325989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
    Ongagna JC; Levy-Marchal C
    Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.
    Verge CF; Howard NJ; Rowley MJ; Mackay IR; Zimmet PZ; Egan M; Hulinska H; Hulinsky I; Silvestrini RA; Kamath S
    Diabetologia; 1994 Nov; 37(11):1113-20. PubMed ID: 7867883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
    Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
    J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
    Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
    Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay.
    Masuda M; Powell M; Chen S; Beer C; Fichna P; Rees Smith B; Furmaniak J
    Clin Chim Acta; 2000 Jan; 291(1):53-66. PubMed ID: 10612717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
    Bingley PJ; Christie MR; Bonifacio E; Bonfanti R; Shattock M; Fonte MT; Bottazzo GF; Gale EA
    Diabetes; 1994 Nov; 43(11):1304-10. PubMed ID: 7926304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
    Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
    Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Islet cell antibodies].
    Hanafusa T
    Rinsho Byori; 1995 May; 43(5):460-2. PubMed ID: 7783363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.